Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not related to Orion

    NEXT STORY
    Clinical Highlights: 15th Annual CMHC Live Online
    PREV STORY
    AzurRx BioPharma Provides Insight into Drawbacks of Using Porcine Products in Production of Pharmaceuticals and Medicinals, Offers Update on Efforts to Produce Synthetic Alternatives
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioNTech to Report Third Quarter 2020 Financial Results and Operational Update on November 10, 2020

    author_avatar
    NASDAQ Market News

    Peter Svennilson Elected to RAPT Therapeutics Board of Directors

    author_avatar
    NASDAQ Market News

    PRIME designation granted by European Medicines Agency for Roche’s risdiplam for treatment of spinal muscular atrophy (SMA)

    Risdiplam has the potential to be the first oral medicine for the treatment of ...

    author_avatar
    NASDAQ Market News